At Boston Atrial Fibrillation Symposium 2010, Dr. Andrea Russo talked about gender differences in atrial fibrillation treatment, including catheter ablation, as well as women and the risk of stroke from afib. Watch the video: Interview with Dr. Andrea Russo at Boston Atrial Fibrillation Symposium 2010
Urgent coordinated action is needed to avoid the thousands of preventable strokes that leave many atrial fibrillation (AF) patients mentally and physically disabled or dead every year. A report, How Can We Avoid a Stroke Crisis?, was launched today in the European Parliament in Brussels by Action for Stroke Prevention, a group of health experts …
A newly published study shows obesity is a major risk factor for left atrial enlargement (LAE), a condition in which the left upper chamber of the heart is oversized. That's important to people who are concerned about atrial fibrillation (AF) because LAE is a risk factor for afib, stroke and death. Read more: Obesity Raises …
This very important story may change how afib patients and their doctors decide if they should be on anticoagulant medications (blood thinners), such as Coumadin or warfarin. The CHADS2 scoring system is how doctors now decide who should be on Coumadin or warfarin to avoid strokes, but a newly-published study adds new stroke risk factors …
A new study reports that blood levels of a protein hormone called N-terminal pro-B-type natriuretic peptide (NT-proBNP) predicts new atrial fibrillation, regardless of other afib risk factors. Those with the highest levels were four times as likely to develop afib as those with the lowest levels. In the study, elevated levels of NT-proBNP occurred as …
We know that more men than women have atrial fibrillation, but that women have a higher rate of strokes and death. In fact, women account for about 61% of stroke deaths. Recent research at Rush University Medical Center identified nine specific gender differences between women and men who have atrial fibrillation. Those included that women …